GOSSVSNRIX• 3 Months (Normalized)
GOSS vs NRIX (Gossamer Bio Inc. vs Nurix Therapeutics Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.73
+6325.15%
Gossamer Bio Inc.
Normalized Baseline0.00%
NRIX Performance $25.1
+47.3%
Nurix Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+6277.85%
GOSS outperforming by 6277.85%
GOSSNRIX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS NRIX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | GOSS Price | GOSS Gain (%) | NRIX Price | NRIX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.73 | +6325.15% | $25.10 | +47.30% | +6277.85% |
| Sep 10, 2026 | $11.36 | +6702.40% | $25.81 | +51.47% | +6650.93% |
| Sep 09, 2026 | $12.80 | +7564.67% | $26.26 | +54.11% | +7510.56% |
| Sep 08, 2026 | $14.40 | +8522.75% | $26.13 | +53.35% | +8469.40% |
| Sep 04, 2026 | $14.00 | +8283.23% | $26.14 | +53.40% | +8229.83% |
| Sep 03, 2026 | $14.05 | +8311.98% | $25.32 | +48.59% | +8263.39% |
| Sep 02, 2026 | $0.17 | +3.59% | $25.82 | +51.53% | -47.94% |
| Sep 01, 2026 | $0.17 | +0.00% | $26.04 | +52.82% | -52.82% |
| Aug 31, 2026 | $0.17 | +1.80% | $25.78 | +51.29% | -49.49% |
| Aug 28, 2026 | $0.17 | +1.80% | $26.21 | +53.81% | -52.01% |
| Aug 27, 2026 | $0.17 | +1.80% | $26.88 | +57.72% | -55.92% |
| Aug 26, 2026 | $0.17 | +4.19% | $26.71 | +56.75% | -52.56% |
| Aug 25, 2026 | $0.21 | +22.75% | $26.95 | +58.16% | -35.41% |
| Aug 24, 2026 | $0.18 | +4.79% | $26.27 | +54.17% | -49.38% |
| Aug 21, 2026 | $0.16 | -7.19% | $26.72 | +56.81% | -64.00% |
Page 1 of 5